Table 2 Bleeding characteristics of study subjects
Variables | Total enrolled patients (n = 41) | UI-EWD monotherapy (n = 23) |
|---|---|---|
Location of the tumor bleeding, n (%) | ||
Esophagus | 3 (7.3) | 2 (8.7) |
Stomach | 33 (80.5) | 20 (87.0) |
Fundus and cardia | 2 (4.9) | 1 (4.3) |
Body | 16 (39.0) | 9 (39.1) |
Antrum | 15 (36.6) | 10 (43.6) |
Duodenum | 5 (12.2) | 1 (4.3) |
Forrest classification, n (%) | ||
Ia | 3 (7.3) | 0 (0.0) |
Ib | 38 (92.7) | 23 (100.0) |
Tumor size (cm)§ | 5 (1–15) | 5 (1–17) |
The treatment modality, n (%) | ||
UI-EWD only | 23 (56.1) | 23 (100.0) |
Coagraspher with UI-EWD | 9 (22.0) | |
APC with UI-EWD | 4 (9.8) | |
Hemoclipping with UI-EWD | 3 (7.3) | |
Epinephrine injection with UI-EWD | 2 (4.9) |